openPR Logo
Press release

Stem Cell Umbilical Cord Blood Market size and Key Trends in terms of volume and value 2016-2024

Stem Cell Umbilical Cord Blood Market size and Key Trends in terms

Umbilical cord blood has become a valuable commodity in the healthcare sector in recent years due to rising awareness about the utility of stem cells in the treatment of a wide variety of diseases. Umbilical cord blood is the blood left over in the placenta after childbirth, and is the best source of stem cells. Stem cells have become vital in the medical field due to their capacity to regenerate into any kind of human cells. This has made them a prime candidate for the treatment of several degenerative diseases that have proven to be beyond mankind so far. Genetic and hematopoietic diseases are also treated with stem cells, further increasing the utility of the umbilical cord blood market to the healthcare sector.

Growing government support has been crucial for the global umbilical cord blood market and is likely to remain the key driver in the coming years. Safe and convenient storage of umbilical cord blood and stem cells requires sophisticated infrastructure, which requires significant government backing in terms of both economic freedom and regulations. The increasing number of governments acknowledging the utility of stem cells and thus umbilical cord blood to the medical sector is thus crucial for the global umbilical cord blood market.

Request Sample Copy of the Report@

Government support has also helped the umbilical cord blood overcome social reservations about the use of stem cells. The intimate nature of umbilical cord blood and the strong emotional ties attached to the childbirth process had made obtaining umbilical cord blood difficult due to lack of popular support. Steady government presence in awareness programs has thus proved important for the umbilical cord blood market. The rising presence of private players in stem cell research is also vital for the global umbilical cord blood market.

Stem Cell Umbilical Cord Blood Market: Overview

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

The cord blood collected during childbirth is cryopreserved and stored. UCB stem cells are stored either at private cord banks or at public cord blood banks. This preserved blood is generally used at the time of treatment of chronic ailments or transplantation, if needed, in the later stages of life.

Governments around the world have been proactively financing campaigns to spread public awareness about the potential benefits of UCB stem cells. This has been a crucial factor boosting the global stem cell umbilical cord blood market in the last few years. Furthermore, such steps taken by governments also provides economic and social benefits.

The report covers the various factors influencing the growth exhibited by the stem cell umbilical cord blood market. It features an in-depth analysis of the key market drivers, restraints, and opportunities. Other highlights of the report include a market attractiveness analysis, representation of prominent enterprises in the market in terms of key shares, competitive analysis, SWOT analysis, and Porter’s five forces analysis.

Stem Cell Umbilical Cord Blood Market: Key Trends and Opportunities

UCB stem cells have emerged as an effective treatment option for over 80 diseases including immunodeficiency disorders, cancer, and other chronic blood disorders. Many of these diseases have no cure but can be treated effectively using stem cells obtained from the umbilical cord. UCB stem cells travel to the location of the damage, identify the infected cells, and then initiate a healing process. Moreover, the risk of rejection is nonexistent, because they are obtained from the same individual.

With research being underway for developing UCB stem cells to effectively treat diseases such as Alzheimer's, diabetes, heart failure, and brain tumor, the future of the global stem cell umbilical cord blood market seems very impressive. Owing to their inherent health benefits, UCB stem cells are identified as a successful mode of treatment for various life-threatening ailments.

Government authorities are also supporting clinical trials and research into cord blood stem cells, which has been a crucial factor increasing the interest of the healthcare industry and compelling major healthcare players to invest in the commercialization of UCB stem cells therapies. For instance, Cytori Therapeutics Inc., Athersys, and California Stem Cell Inc. are engaged in developing novel stem cell therapies from UCB stem cells. This is a key factor offering impetus to the global market for stem cell umbilical cord blood.

Request TOC of the Report@

Stem Cell Umbilical Cord Blood Market: Competitive Outlook

Competition prevailing in the global stem cell umbilical cord blood market is currently intense, with enterprises focusing mainly on creating brand awareness. This is compelling enterprises operating in the market to formulate innovative strategies. To study the competition prevailing in the market, the report profiles companies such as Nuo Therapeutics, Teva Pharmaceuticals, Cytori Therapeutics, and others.

These companies are studied on the basis of their financial overview, business structure, supply chain network, strategies adopted, and current development status.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Middle East and Africa
Latin America

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem Cell Umbilical Cord Blood Market size and Key Trends in terms of volume and value 2016-2024 here

News-ID: 704140 • Views: 282

More Releases from Transparency Market Research

Wound Care Market Share Analysis, Advancement and Precise Outlook – 2024
Global Wound Care Market: Overview Over the years, the wound care market has become more technology intensive. Interested health care companies and medical device makers have poured in large amounts in research and development activities, expanding the scope of wound care. View Report : The product landscape is heavily influenced by competitive pricing strategies adopted by numerous top players. These players have considerably advanced the scope of product innovations to meet
Healthcare EDI Market Trends by Manufacturers, States, Type and Application
Global Healthcare EDI Market: Overview Management of data such as patient history records, emergency services records, and medication data is of critical importance in the healthcare industry. Healthcare professionals are acknowledging systems that are capable of managing massive data in an efficient, systematic, and easily accessible manner. As a result, electronic data interchange (EDI) is being implemented across all sub-divisions of the industry. View Report : Some of the key applications
Mobile Medical Apps Market Size Industry Analysis, Size, Trends, Growth And Outl …
Over the past few years, medical mobile apps have made rapid emergence in the healthcare industry. Their role in improving patient experience has intensified more than ever, and have helped proponents of patient care providers to overcome geographical barriers. Concomitantly, medical apps used by mobile users have also proliferated in numbers. The most crucial difference is probably stark in the growing use of diagnostic information and reminders by patients through
Analysis of COVID-19 Crisis-driven Growth Opportunities in Medical Bioinformatic …
Bioinformatics involves the development and application of novel informatics techniques in the field of biology. It improves the methods of storing, organizing, retrieving and analyzing biological data. Major activity in bioinformatics is to develop software tools in order to generate useful biological knowledge database. In molecular biology, bioinformatics techniques such as signal processing allow extraction of useful results from large amount of raw data. In the field of genetics it

All 5 Releases

More Releases for UCB

Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons
Global Epilepsy Drugs Market 2018 - UCB, Cephalon, Shire, Eisai, Pfizer
Eminent Market, recently published a detailed market research study focused on the "Epilepsy Drugs Market" across the global, regional and country level. The report provides 360° analysis of "Epilepsy Drugs Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epilepsy Drugs industry, and estimates the future trend of Epilepsy Drugs market on
UCB Banking Market Predicted to Rake $19,335.6 Mn in 2020
The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market. Browse Complete Report @ According to a new market report published by Persistence Market Research “Global
UCB Banking Market Will Procure $19,335.6 million in 2020
The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market. Browse Complete Report @ According to a new market report published by Persistence Market Research “Global
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021. Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing
Cetirizine Hydrochloride Market 2017- UCB Pharma, Pfizer, J & J, Mylan
Cetirizine Hydrochloride Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist. Second-generation antihistamines like cetirizine